Corient Private Wealth’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19,825
Closed -$8.96K 2694
2025
Q2
$8.96K Hold
19,825
﹤0.01% 2423
2025
Q1
$8.07K Hold
19,825
﹤0.01% 2266
2024
Q4
$13.1K Hold
19,825
﹤0.01% 2316
2024
Q3
$16.8K Hold
19,825
﹤0.01% 2435
2024
Q2
$13.2K Hold
19,825
﹤0.01% 2302
2024
Q1
$25.8K Sell
19,825
-300
-1% -$314 ﹤0.01% 2252
2023
Q4
$11.5K Buy
20,125
+1,500
+8% +$1.04K ﹤0.01% 2233
2023
Q3
$14K Buy
18,625
+300
+2% +$228 ﹤0.01% 2116
2023
Q2
$13.4K Hold
18,325
﹤0.01% 2060
2023
Q1
$13.9K Hold
18,325
﹤0.01% 1983
2022
Q4
$17.6K Buy
+18,325
New +$25.9K ﹤0.01% 1669

Other funds holding VXRT

Corient Private Wealth's VXRT Position: Q3 2025 in Review

Corient Private Wealth sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 19,825 shares — an estimated $8.96K sold.

Corient Private Wealth first reported a position in VXRT in Q4 2022 and held it in 11 quarters. The position peaked at $25.8K in Q1 2024. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Corient Private Wealth reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Corient Private Wealth sold 19,825 Vaxart shares in Q3 2025, an estimated $8.96K.
  • Corient Private Wealth first reported a position in Vaxart in Q4 2022 and held it in 11 quarters.
  • Corient Private Wealth's Vaxart position peaked at $25.8K in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Corient Private Wealth's 13F filing for Q3 2025, filed 14 Nov 2025.